Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer

Affiliations

¹ The University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: rdalvarez@uab.edu.
² Dana-Farber Cancer Institute, Boston, MA, United States.
³ UC Cancer Institute, The University of Cincinnati, Cincinnati, OH, United States.
⁴ The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
⁵ University of Arizona Cancer Center, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
⁶ Cancer Treatment Centers of America, Philadelphia, PA, United States.

Editorial

Ronald D Alvarez et al. Gynecol Oncol. 2016 Jun.

. 2016 Jun;141(3):405-409.

doi: 10.1016/j.ygyno.2016.03.005. Epub 2016 Apr 8.

¹ The University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: rdalvarez@uab.edu.
² Dana-Farber Cancer Institute, Boston, MA, United States.
³ UC Cancer Institute, The University of Cincinnati, Cincinnati, OH, United States.
⁴ The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
⁵ University of Arizona Cancer Center, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
⁶ Cancer Treatment Centers of America, Philadelphia, PA, United States.

No abstract available

Keywords: Platinum sensitive/resistant; Recurrent ovarian cancer.

Publication types